Locally Advanced Prostate Cancer: Optimal Therapy in Older Patients

被引:2
作者
Froehner, Michael [1 ]
Wirth, Manfred P. [1 ]
机构
[1] Tech Univ Dresden, Dept Urol, Univ Hosp Carl Gustav Carus, D-01304 Dresden, Germany
关键词
ANDROGEN-DEPRIVATION THERAPY; RADICAL PROSTATECTOMY; FOLLOW-UP; BIOCHEMICAL RECURRENCE; CARDIOVASCULAR DEATH; FUNCTIONAL OUTCOMES; RADIATION-THERAPY; ONCOLOGY-GROUP; MEN; ASSOCIATION;
D O I
10.1007/s40266-013-0123-7
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
There is no standard treatment for locally advanced prostate cancer. Even the definition is still unclear. Locally advanced disease may refer to over-staged well-curable tumors as well as to advanced and probably incurable cancers. Similar uncertainties are present regarding the definition of 'old' in this context. Conservatively treated locally advanced prostate cancer is associated with poor survival outcome. With the increasing life expectancy, in the absence of curative treatment, even patients in their ninth decade of life may later suffer from symptoms of aggressive prostate cancer and are at a high risk of death from prostate cancer that might be prevented at least in part by early intervention. On the other hand, functional results after prostate cancer treatment are worse in elderly patients. In this article we discuss aspects of the management of locally advanced prostate cancer in the elderly with special focus on the recommendation of current clinical guidelines.
引用
收藏
页码:959 / 967
页数:9
相关论文
共 50 条
  • [31] Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
    Gillessen, Silke
    Bossi, Alberto
    Davis, Ian D.
    de Bono, Johann
    Fizazi, Karim
    James, Nicholas D.
    Mottet, Nicolas
    Shore, Neal
    Small, Eric
    Smith, Mathew
    Sweeney, Christopher
    Tombal, Bertrand
    Antonarakis, Emmanuel S.
    Aparicio, Ana M.
    Armstrong, Andrew J.
    Attard, Gerhardt
    Beer, Tomasz M.
    Beltran, Himisha
    Bjartell, Anders
    Blanchard, Pierre
    Briganti, Alberto
    Bristow, Rob G.
    Bulbul, Muhammad
    Caffo, Orazio
    Castellano, Daniel
    Castro, Elena
    Cheng, Heather H.
    Chi, Kim N.
    Chowdhury, Simon
    Clarke, Caroline S.
    Clarke, Noel
    Daugaard, Gedske
    De, Maria
    Duran, Ignacio
    Eeles, Ros
    Efstathiou, Eleni
    Efstathiou, Jason
    Ekeke, Onyeanunam Ngozi
    Evans, Christopher P.
    Fanti, Stefano
    Feng, Felix Y.
    Fonteyne, Valerie
    Fossati, Nicola
    Frydenberg, Mark
    Daniel, Vvww
    Gleave, Martin
    Gravis, Gwenaelle
    Halabi, Susan
    Heinrich, Daniel
    Herrmann, Ken
    EUROPEAN UROLOGY, 2023, 83 (03) : 267 - 293
  • [32] Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer
    Iwamoto, Hiroaki
    Izumi, Kouji
    Makino, Tomoyuki
    Mizokami, Atsushi
    CANCERS, 2022, 14 (07)
  • [33] Salvage therapy for locally recurrent prostate cancer after radiation
    Marcus, David M.
    Canter, Daniel J.
    Jani, Ashesh B.
    Dobbs, Ryan W.
    Schuster, David M.
    Carthon, Bradley C.
    Rossi, Peter J.
    CANADIAN JOURNAL OF UROLOGY, 2012, 19 (06) : 6534 - 6541
  • [34] Treatment strategies for high-risk locally advanced prostate cancer
    Rosenthal, Seth A.
    Sandler, Howard M.
    NATURE REVIEWS UROLOGY, 2010, 7 (01) : 31 - 38
  • [35] Postoperative Radiotherapy in Locally Advanced Prostate Cancer: A Question of Who and When
    Wallis, Christopher J. D.
    Satkunasivam, Raj
    Nam, Robert K.
    EUROPEAN UROLOGY, 2017, 71 (06) : 894 - 895
  • [36] Optimal Management of Recurrent Prostate Cancer in Older Patients
    Kessler, Elizabeth R.
    Flaig, Thomas W.
    DRUGS & AGING, 2012, 29 (11) : 871 - 883
  • [37] Efficacy of neoadjuvant docetaxel plus cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations
    Chi, Chenfei
    Liu, Jiazhou
    Fan, Liancheng
    Zhu, Yinjie
    Wang, Yanqing
    Sha, Jianjun
    Huang, Yiran
    Dong, Baijun
    Pan, Jiahua
    Xue, Wei
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [38] The importance of combined radiation and endocrine therapy in locally advanced prostate cancer
    Gray, Phillip J.
    Shipley, William U.
    ASIAN JOURNAL OF ANDROLOGY, 2012, 14 (02) : 245 - 246
  • [39] Radiation therapy for prostate cancer in the new S3 guideline - Part 1: localized and locally advanced prostate cancer
    Boehmer, D.
    Wenz, F.
    Martin, T.
    Sedlmayr, F.
    Hinkelbein, W.
    Wiegel, T.
    UROLOGE, 2010, 49 (02): : 211 - 215
  • [40] Optimal Management of Recurrent Prostate Cancer in Older Patients
    Elizabeth R. Kessler
    Thomas W. Flaig
    Drugs & Aging, 2012, 29 : 871 - 883